Rozani S, Lykoudis PM. Overcoming geographical and socioeconomic limitations in colorectal cancer screening. World J Gastrointest Oncol 2024; 16(5): 1683-1689 [PMID: 38764845 DOI: 10.4251/wjgo.v16.i5.1683]
Corresponding Author of This Article
Panagis M Lykoudis, MD, MSc, PhD, Lecturer, Division of Surgery and Interventional Science, University College London, Gower Street, London WC1E 6BT, United Kingdom. p.lykoudis@ucl.ac.uk
Research Domain of This Article
Health Policy & Services
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. May 15, 2024; 16(5): 1683-1689 Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.1683
Overcoming geographical and socioeconomic limitations in colorectal cancer screening
Sofia Rozani, Panagis M Lykoudis
Sofia Rozani, Panagis M Lykoudis, School of Medicine, National and Kapodistrian University of Athens, Athens 11527, Greece
Panagis M Lykoudis, Division of Surgery and Interventional Science, University College London, London WC1E 6BT, United Kingdom
Author contributions: Rozani S and Lykoudis PM contributed equally to this work.
Conflict-of-interest statement: All authors have no relevant conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Panagis M Lykoudis, MD, MSc, PhD, Lecturer, Division of Surgery and Interventional Science, University College London, Gower Street, London WC1E 6BT, United Kingdom. p.lykoudis@ucl.ac.uk
Received: December 30, 2023 Peer-review started: December 30, 2023 First decision: January 16, 2024 Revised: January 29, 2024 Accepted: March 18, 2024 Article in press: March 18, 2024 Published online: May 15, 2024 Processing time: 130 Days and 17.5 Hours
Core Tip
Core Tip: The high colorectal cancer (CRC) mortality rate worldwide, despite the adequate availability of modern screening, diagnostic and treatment options, raises important research and clinical questions. In both low- and middle- income countries (LMICs), and minority populations of high-income countries, the paradox of underutilization of existing screening methods was observed. The lack of global, homogeneous guidelines and the absence of guidelines addressing CRC screening at the national level for LMICs, contribute to the confusing status in the management of screening of aforementioned populations. Global efforts should focus on medical education and vigilance of medical healthcare providers and patients, on exploring the socio-economic aspects, and on the use of technological innovations in telemedicine and artificial intelligence in clinical practice.
